ES412387A1 - Procedimiento para la obtencion de formulaciones mejoradas del sabor de penicilinas orales. - Google Patents

Procedimiento para la obtencion de formulaciones mejoradas del sabor de penicilinas orales.

Info

Publication number
ES412387A1
ES412387A1 ES412387A ES412387A ES412387A1 ES 412387 A1 ES412387 A1 ES 412387A1 ES 412387 A ES412387 A ES 412387A ES 412387 A ES412387 A ES 412387A ES 412387 A1 ES412387 A1 ES 412387A1
Authority
ES
Spain
Prior art keywords
formulation
oral administration
penicillins
improved taste
taste properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES412387A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES412387A1 publication Critical patent/ES412387A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES412387A 1972-03-08 1973-03-07 Procedimiento para la obtencion de formulaciones mejoradas del sabor de penicilinas orales. Expired ES412387A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2211019A DE2211019C3 (de) 1972-03-08 1972-03-08 Geschmacksverbessernde Formulierungen oraler Penicilline

Publications (1)

Publication Number Publication Date
ES412387A1 true ES412387A1 (es) 1976-01-16

Family

ID=5838215

Family Applications (1)

Application Number Title Priority Date Filing Date
ES412387A Expired ES412387A1 (es) 1972-03-08 1973-03-07 Procedimiento para la obtencion de formulaciones mejoradas del sabor de penicilinas orales.

Country Status (14)

Country Link
US (1) US3872227A (es)
JP (1) JPS4899317A (es)
AT (1) AT326819B (es)
BE (1) BE796446A (es)
DE (1) DE2211019C3 (es)
DK (1) DK132738C (es)
ES (1) ES412387A1 (es)
FR (1) FR2181804B1 (es)
GB (1) GB1388358A (es)
HU (1) HU167988B (es)
IE (1) IE37378B1 (es)
IL (1) IL41686A (es)
NL (1) NL7303207A (es)
ZA (1) ZA731589B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2832009A1 (de) * 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
US5637618A (en) * 1990-06-01 1997-06-10 Bioresearch, Inc. Specific eatable taste modifiers
US5631038A (en) * 1990-06-01 1997-05-20 Bioresearch, Inc. Specific eatable taste modifiers
SK62094A3 (en) * 1991-11-27 1995-04-12 Bioresearch Inc Specific eatable taste modifiers
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5622723A (en) * 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
US7504376B2 (en) * 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
CH690817A5 (de) 1996-09-03 2001-01-31 Flachsmann Ag Emil Verfahren zur Herstellung eines stabilen, homogenen, von Folgeprodukten freien oder nahezu freien Extraktes.
WO2000038536A2 (en) 1998-12-23 2000-07-06 Mount Sinai School Of Medicine Of New York University Inhibitors of the bitter taste response
DK1424997T3 (da) * 2001-09-14 2008-01-07 Scolr Inc Aminosyremoduleret dosisform til forlænget frigivelse
JP2006052169A (ja) * 2004-08-12 2006-02-23 Wakoudou Kk ゾル状又はゲル状の服薬補助食品
US7452563B2 (en) * 2005-06-20 2008-11-18 Redpoint Bio Corporation Compositions and methods for producing flavored seasonings that contain reduced quantities of common salt
US7455872B2 (en) * 2005-06-20 2008-11-25 Redpoint Bio Corporation Compositions and methods for producing a salty taste in foods or beverages
FR2963239B1 (fr) * 2010-08-02 2013-03-08 Vetalis Formes galeniques effervescentes solides pour animaux
CN105377236B (zh) 2013-07-18 2019-04-23 桑多斯股份公司 用于抗生素干糖浆制剂的粉末混合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1477464A (fr) * 1964-12-03 1967-04-21 Bayer Ag Procédé pour diminuer les altérations de goût et d'odeur des pénicillines
GB1291282A (en) * 1969-03-20 1972-10-04 Pfizer Ltd Improvements in pharmaceutical compositions

Also Published As

Publication number Publication date
AT326819B (de) 1975-12-29
IE37378L (en) 1973-09-08
JPS4899317A (es) 1973-12-15
FR2181804B1 (es) 1976-10-22
DE2211019B2 (de) 1979-12-20
ATA196073A (de) 1975-03-15
ZA731589B (en) 1973-11-28
AU5295473A (en) 1974-09-12
DE2211019A1 (de) 1973-09-13
IL41686A (en) 1976-10-31
NL7303207A (es) 1973-09-11
DK132738C (da) 1976-07-05
IL41686A0 (en) 1973-05-31
IE37378B1 (en) 1977-07-06
DK132738B (da) 1976-02-02
BE796446A (fr) 1973-09-10
FR2181804A1 (es) 1973-12-07
HU167988B (es) 1976-02-28
US3872227A (en) 1975-03-18
DE2211019C3 (de) 1980-08-28
GB1388358A (en) 1975-03-26

Similar Documents

Publication Publication Date Title
ES412387A1 (es) Procedimiento para la obtencion de formulaciones mejoradas del sabor de penicilinas orales.
AU461863B2 (en) Propanolamine derivatives, their preparation and therapeutic compositions containing thesame
IL42459A0 (en) Medicament formulations having controlled residence time in the gastric region
IL34878A (en) Hydrochloric acid hydrochloride and hydrobromide acid annex salts of N - carboxy - arginine and N - carboxy - histidine and their preparation
CA943128A (en) Penicillins, their preparation and their pharmaceutical use
IL40123A (en) 2-amino-4-phenyl-2-imidazolines and pharmaceutically acceptable acid addition salts thereof and methods for their preparation
PH10188A (en) 6-(l-3-acylamidoacetamido)-penicillanic acids,their pharmaceutically acceptable salts and their medicinal uses
CA976970A (en) N-((diamino, 2',4' aza 3') phenyl)-benzoquinones imines
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
CA986022A (en) Dental treatment compositions including n-monochloroglycine
CA919699A (en) 3,4,5-dialkoxy-monohydroxy-benzoyl aminoalkanoic acids, salts thereof and process for preparing same
CA999238A (en) Oral or dental preparation
ES404317A1 (es) Un procedimiento para la preparacion de sales 4-cloro-m-to-luensulfonicas o 3,4-diclorobenzosulfonicas.
ES401672A1 (es) Un procedimiento para la preparacion de 5,6 - dihidro-8, 8-dimetil-3-nitro-8h-imidazo (2,-1-c) (1,4)-oxacina y sus sa- les de adicion de acido.
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
NO138562C (no) Analogifremgangsmaate for fremstilling av aminoderivater av 2,2-diaryl-cyklopropan med terapeutisk virkning
IL41039A0 (en) Guanidino penicillins,their preparation and pharmaceutical compositions containing them
IL41188A0 (en) Phenylalanine derivatives,their preparation and pharmaceutical compositions containing them
GB1408339A (en) 5,6,7,7alpha-tetrahydro-1h-pyrrolo 1,2-c imidazole-5- carboxylic acids and derivatives thereof
CA887699A (en) Polyamides having improved solubility and freeze-thaw characteristics
ES370501A1 (es) Procedimiento para la preparacion de una hidracida
IL36499A0 (en) 1,2,4-oxadiazoline derivatives,their preparation and pharmaceutical compositions containing them
FR2036801A1 (en) Coccidiostatic preparation containing antibiotic x-537a or a salt ther - eof
JO976B1 (en) 8 Edrox erythromycin and its derivatives, method of preparation and the formulations contained in it
IL41110A (en) Alpha-(heterocyclylacetoxy)-alkanoyl 6-aminopenicillanic acid derivatives,their manufacture and pharmaceutical compositions containing them